|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/00 | (2006.01) |
| A61K 39/39 | (2006.01) |
| (11) | Number of the document | 3423087 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17709038.8 |
| Date of filing the European patent application | 2017-03-03 | |
| (97) | Date of publication of the European application | 2019-01-09 |
| (45) | Date of publication and mention of the grant of the patent | 2023-11-15 |
| (46) | Date of publication of the claims translation | 2024-01-25 |
| (86) | Number | PCT/EP2017/055093 |
| Date | 2017-03-03 |
| (87) | Number | WO 2017/149150 |
| Date | 2017-09-08 |
| (30) | Number | Date | Country code |
| 201603805 | 2016-03-04 | GB | |
| 201610018 | 2016-06-08 | GB |
| (72) |
ANDERSEN, Mads, Hald , DK
|
| (73) |
IO Biotech APS ,
Ole Maaløes Vej 3, 2200 Copenhagen N,
DK
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Kompleksinė priešvėžinė terapija |
| COMBINATION THERAPY AGAINST CANCER |
| Payment date | Validity (years) | Amount | |
| 2026-01-21 | 10 | 231.00 EUR |
| 2027-03-03 |